Economic burden of healthcare-associated infections: an American perspective
- PMID: 19817525
- PMCID: PMC2827870
- DOI: 10.1586/erp.09.53
Economic burden of healthcare-associated infections: an American perspective
Abstract
Annually, approximately 2 million patients suffer with healthcare-associated infections (HAIs) in the USA, and nearly 90,000 are estimated to die. The overall direct cost of HAIs to hospitals ranges from US$28 billion to 45 billion. While the range is wide, HAIs are clearly expensive. In addition, most HAIs are thought to be preventable; however, published guidelines are not congruent. Important policy changes include mandating hospitals to publically report HAI rates and a federal pay-for-performance measure that will no longer allow Medicare to pay more for patients with HAIs. Further rigorous economic evaluations of specific interventions, as well as on evaluations of the policies, are required.
References
-
- Institute of Medicine. To Err is Human: Building a Safer Health System. DC, USA: National Academy Press; 2000. - PubMed
-
- CDC. Public health focus: surveillance, prevention and control of nosocomial infections. MMWR Morb. Mortal. Wkly Rep. 1992;41(42):783–787. - PubMed
-
-
Department of Health and Human Services. HHS Action Plan To Prevent Healthcare-Associated Infections. DC, USA: US Department of Health and Human Services; 2009. . • Outlines the action plan by the federal government to prevent healthcare-associated infections (HAIs).
-
-
- Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990–2000. Am. J. Infect. Control. 2002;30(3):145–152. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical